As families in Europe clamor for gene therapy, Novartis creates a lottery
The move drew criticism from patient groups over concerns the lottery system would unfairly forsake babies who are at risk from dying from the rare disease.
Related Articles
Pharmalittle: We’re reading about FDA morale, pharma removing DEI goals, and more
Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale
New evidence suggests bird flu in veterinarians went undetected
Plus more health news you need to read this morning.
Corbus reports first Western data for closely tracked ADC cancer drug
Corbus Pharmaceuticals presented new data from the first Western study of its antibody-drug conjugate treatment for cancer.
The doctor indicted by Louisiana for prescribing abortion pills saved my life
“If helping others and saving lives are crimes, perhaps we should all be criminals,” writes Maya Gottfried.
U.S. scientists, unnerved by policy changes, may yearn for escape — but find limited opportunity
U.S. scientists, unnerved by policy changes initiated by the Trump administration, may yearn for escape — but find limited opportunity elsewhere.
There is no ‘amyloid cabal’ in Alzheimer’s research
“There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.”
Funding for military health study of LGBTQ+ veterans withdrawn
The Defense Department on Thursday abruptly reversed a decision to fund a military health study of LGBTQ+ veterans, saying it was “not in line” with…
Judge rules lawsuit over UnitedHealth’s AI care denials can move forward
Medicare Advantage beneficiaries who are suing UnitedHealth Group over allegedly wrongful denials of care that were based on artificial intelligence scored a victory Thursday.
Second top NIH official, who oversaw awarding of research grants, departs abruptly
Michael Lauer, deputy director of the National Institutes of Health’s extramural research, will leave the agency at the end of the week.
Growing number of federal health agencies are combing grants for taboo words, unnerving researchers
The National Institutes of Health and some VA regions are scouring existing grants using lists of flagged words, which include not just known trigger